IBDEI0SN ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,12892,1,3,0)
;;=3^Exudative Retinopathy,OD
;;^UTILITY(U,$J,358.3,12892,1,4,0)
;;=4^H35.021
;;^UTILITY(U,$J,358.3,12892,2)
;;=^5005586
;;^UTILITY(U,$J,358.3,12893,0)
;;=H35.022^^51^623^42
;;^UTILITY(U,$J,358.3,12893,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12893,1,3,0)
;;=3^Exudative Retinopathy,OS
;;^UTILITY(U,$J,358.3,12893,1,4,0)
;;=4^H35.022
;;^UTILITY(U,$J,358.3,12893,2)
;;=^5005587
;;^UTILITY(U,$J,358.3,12894,0)
;;=H35.09^^51^623^37
;;^UTILITY(U,$J,358.3,12894,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12894,1,3,0)
;;=3^Intraretinal Microvascular Abnormalities,Other
;;^UTILITY(U,$J,358.3,12894,1,4,0)
;;=4^H35.09
;;^UTILITY(U,$J,358.3,12894,2)
;;=^268617
;;^UTILITY(U,$J,358.3,12895,0)
;;=H35.23^^51^623^46
;;^UTILITY(U,$J,358.3,12895,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12895,1,3,0)
;;=3^Non-Diabetic Proliferative Retinopathy,Other,OU
;;^UTILITY(U,$J,358.3,12895,1,4,0)
;;=4^H35.23
;;^UTILITY(U,$J,358.3,12895,2)
;;=^5005645
;;^UTILITY(U,$J,358.3,12896,0)
;;=H35.21^^51^623^44
;;^UTILITY(U,$J,358.3,12896,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12896,1,3,0)
;;=3^Non-Diabetic Proliferative Retinopathy,Other,OD
;;^UTILITY(U,$J,358.3,12896,1,4,0)
;;=4^H35.21
;;^UTILITY(U,$J,358.3,12896,2)
;;=^5005643
;;^UTILITY(U,$J,358.3,12897,0)
;;=H35.22^^51^623^45
;;^UTILITY(U,$J,358.3,12897,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12897,1,3,0)
;;=3^Non-Diabetic Proliferative Retinopathy,Other,OS
;;^UTILITY(U,$J,358.3,12897,1,4,0)
;;=4^H35.22
;;^UTILITY(U,$J,358.3,12897,2)
;;=^5005644
;;^UTILITY(U,$J,358.3,12898,0)
;;=H35.043^^51^623^30
;;^UTILITY(U,$J,358.3,12898,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12898,1,3,0)
;;=3^Retinal Micro-Aneurysms,Unspec,OU
;;^UTILITY(U,$J,358.3,12898,1,4,0)
;;=4^H35.043
;;^UTILITY(U,$J,358.3,12898,2)
;;=^5005596
;;^UTILITY(U,$J,358.3,12899,0)
;;=H35.041^^51^623^28
;;^UTILITY(U,$J,358.3,12899,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12899,1,3,0)
;;=3^Retinal Micro-Aneurysms,Unspec,OD
;;^UTILITY(U,$J,358.3,12899,1,4,0)
;;=4^H35.041
;;^UTILITY(U,$J,358.3,12899,2)
;;=^5005594
;;^UTILITY(U,$J,358.3,12900,0)
;;=H35.042^^51^623^29
;;^UTILITY(U,$J,358.3,12900,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12900,1,3,0)
;;=3^Retinal Micro-Aneurysms,Unspec,OS
;;^UTILITY(U,$J,358.3,12900,1,4,0)
;;=4^H35.042
;;^UTILITY(U,$J,358.3,12900,2)
;;=^5005595
;;^UTILITY(U,$J,358.3,12901,0)
;;=H35.053^^51^623^33
;;^UTILITY(U,$J,358.3,12901,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12901,1,3,0)
;;=3^Retinal Neovascularization,Unspec,OU
;;^UTILITY(U,$J,358.3,12901,1,4,0)
;;=4^H35.053
;;^UTILITY(U,$J,358.3,12901,2)
;;=^5005600
;;^UTILITY(U,$J,358.3,12902,0)
;;=H35.051^^51^623^31
;;^UTILITY(U,$J,358.3,12902,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12902,1,3,0)
;;=3^Retinal Neovascularization,Unspec,OD
;;^UTILITY(U,$J,358.3,12902,1,4,0)
;;=4^H35.051
;;^UTILITY(U,$J,358.3,12902,2)
;;=^5005598
;;^UTILITY(U,$J,358.3,12903,0)
;;=H35.052^^51^623^32
;;^UTILITY(U,$J,358.3,12903,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12903,1,3,0)
;;=3^Retinal Neovascularization,Unspec,OS
;;^UTILITY(U,$J,358.3,12903,1,4,0)
;;=4^H35.052
;;^UTILITY(U,$J,358.3,12903,2)
;;=^5005599
;;^UTILITY(U,$J,358.3,12904,0)
;;=H35.073^^51^623^36
;;^UTILITY(U,$J,358.3,12904,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0SN 3749 printed Sep 23, 2025@19:30:58 Page 2
IBDEI0SN ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,12892,1,3,0)
+2 ;;=3^Exudative Retinopathy,OD
+3 ;;^UTILITY(U,$J,358.3,12892,1,4,0)
+4 ;;=4^H35.021
+5 ;;^UTILITY(U,$J,358.3,12892,2)
+6 ;;=^5005586
+7 ;;^UTILITY(U,$J,358.3,12893,0)
+8 ;;=H35.022^^51^623^42
+9 ;;^UTILITY(U,$J,358.3,12893,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,12893,1,3,0)
+12 ;;=3^Exudative Retinopathy,OS
+13 ;;^UTILITY(U,$J,358.3,12893,1,4,0)
+14 ;;=4^H35.022
+15 ;;^UTILITY(U,$J,358.3,12893,2)
+16 ;;=^5005587
+17 ;;^UTILITY(U,$J,358.3,12894,0)
+18 ;;=H35.09^^51^623^37
+19 ;;^UTILITY(U,$J,358.3,12894,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,12894,1,3,0)
+22 ;;=3^Intraretinal Microvascular Abnormalities,Other
+23 ;;^UTILITY(U,$J,358.3,12894,1,4,0)
+24 ;;=4^H35.09
+25 ;;^UTILITY(U,$J,358.3,12894,2)
+26 ;;=^268617
+27 ;;^UTILITY(U,$J,358.3,12895,0)
+28 ;;=H35.23^^51^623^46
+29 ;;^UTILITY(U,$J,358.3,12895,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,12895,1,3,0)
+32 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OU
+33 ;;^UTILITY(U,$J,358.3,12895,1,4,0)
+34 ;;=4^H35.23
+35 ;;^UTILITY(U,$J,358.3,12895,2)
+36 ;;=^5005645
+37 ;;^UTILITY(U,$J,358.3,12896,0)
+38 ;;=H35.21^^51^623^44
+39 ;;^UTILITY(U,$J,358.3,12896,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,12896,1,3,0)
+42 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OD
+43 ;;^UTILITY(U,$J,358.3,12896,1,4,0)
+44 ;;=4^H35.21
+45 ;;^UTILITY(U,$J,358.3,12896,2)
+46 ;;=^5005643
+47 ;;^UTILITY(U,$J,358.3,12897,0)
+48 ;;=H35.22^^51^623^45
+49 ;;^UTILITY(U,$J,358.3,12897,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,12897,1,3,0)
+52 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OS
+53 ;;^UTILITY(U,$J,358.3,12897,1,4,0)
+54 ;;=4^H35.22
+55 ;;^UTILITY(U,$J,358.3,12897,2)
+56 ;;=^5005644
+57 ;;^UTILITY(U,$J,358.3,12898,0)
+58 ;;=H35.043^^51^623^30
+59 ;;^UTILITY(U,$J,358.3,12898,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,12898,1,3,0)
+62 ;;=3^Retinal Micro-Aneurysms,Unspec,OU
+63 ;;^UTILITY(U,$J,358.3,12898,1,4,0)
+64 ;;=4^H35.043
+65 ;;^UTILITY(U,$J,358.3,12898,2)
+66 ;;=^5005596
+67 ;;^UTILITY(U,$J,358.3,12899,0)
+68 ;;=H35.041^^51^623^28
+69 ;;^UTILITY(U,$J,358.3,12899,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,12899,1,3,0)
+72 ;;=3^Retinal Micro-Aneurysms,Unspec,OD
+73 ;;^UTILITY(U,$J,358.3,12899,1,4,0)
+74 ;;=4^H35.041
+75 ;;^UTILITY(U,$J,358.3,12899,2)
+76 ;;=^5005594
+77 ;;^UTILITY(U,$J,358.3,12900,0)
+78 ;;=H35.042^^51^623^29
+79 ;;^UTILITY(U,$J,358.3,12900,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,12900,1,3,0)
+82 ;;=3^Retinal Micro-Aneurysms,Unspec,OS
+83 ;;^UTILITY(U,$J,358.3,12900,1,4,0)
+84 ;;=4^H35.042
+85 ;;^UTILITY(U,$J,358.3,12900,2)
+86 ;;=^5005595
+87 ;;^UTILITY(U,$J,358.3,12901,0)
+88 ;;=H35.053^^51^623^33
+89 ;;^UTILITY(U,$J,358.3,12901,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,12901,1,3,0)
+92 ;;=3^Retinal Neovascularization,Unspec,OU
+93 ;;^UTILITY(U,$J,358.3,12901,1,4,0)
+94 ;;=4^H35.053
+95 ;;^UTILITY(U,$J,358.3,12901,2)
+96 ;;=^5005600
+97 ;;^UTILITY(U,$J,358.3,12902,0)
+98 ;;=H35.051^^51^623^31
+99 ;;^UTILITY(U,$J,358.3,12902,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,12902,1,3,0)
+102 ;;=3^Retinal Neovascularization,Unspec,OD
+103 ;;^UTILITY(U,$J,358.3,12902,1,4,0)
+104 ;;=4^H35.051
+105 ;;^UTILITY(U,$J,358.3,12902,2)
+106 ;;=^5005598
+107 ;;^UTILITY(U,$J,358.3,12903,0)
+108 ;;=H35.052^^51^623^32
+109 ;;^UTILITY(U,$J,358.3,12903,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,12903,1,3,0)
+112 ;;=3^Retinal Neovascularization,Unspec,OS
+113 ;;^UTILITY(U,$J,358.3,12903,1,4,0)
+114 ;;=4^H35.052
+115 ;;^UTILITY(U,$J,358.3,12903,2)
+116 ;;=^5005599
+117 ;;^UTILITY(U,$J,358.3,12904,0)
+118 ;;=H35.073^^51^623^36
+119 ;;^UTILITY(U,$J,358.3,12904,1,0)
+120 ;;=^358.31IA^4^2
